Fundz

Ascidian Therapeutics Appoints Murray A. Abramson as Chief Development Officer

PRIVATEJun 24, 2025

Position

Chief Development Officer

Company

Ascidian Therapeutics

Murray A. Abramson
mabramson@ascidian-tx.com
BostonBiotechnologyHealth CareMedicalTherapeutics

Description

Ascidian Therapeutics announces the appointment of Murray A. Abramson, MD, MPH, as Chief Development Officer. With extensive experience in clinical development, Dr Abramson will lead the clinical strategy for the company's RNA editing therapeutics.

Quick answer

Ascidian Therapeutics Appoints Murray A. Abramson as Chief Development Officer (June 24, 2025). Ascidian Therapeutics is based in Boston, Massachusetts, United States.

Who is the new Chief Development Officer at Ascidian Therapeutics?
Ascidian Therapeutics named Murray A. Abramson Chief Development Officer, announced June 24, 2025.
What did Ascidian Therapeutics announce on June 24, 2025?
Ascidian Therapeutics announces the appointment of Murray A. Abramson, MD, MPH, as Chief Development Officer. With extensive experience in clinical development, Dr Abramson will lead the clinical strategy for the company's RNA editing therapeutics.
What does Ascidian Therapeutics do?
Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA.
Where is Ascidian Therapeutics based?
Ascidian Therapeutics is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Vivex Biologics (June 10, 2025), Tivic (July 8, 2025), Lobe Sciences (June 3, 2025) and Elite Clinical Network (ECN) (June 2, 2025) also announced leadership changes within 45 days of Ascidian Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ascidian Therapeutics, and when

A new leader at Ascidian Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ascidian Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ascidian Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ascidian Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ascidian Therapeutics

Location

Boston, Massachusetts, United States

About

Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right levels, in the right cells, at the right time. With active discovery and preclinical programs in ophthalmology, neurological and neuromuscular disorders, and other rare diseases, Ascidian is opening new therapeutic possibilities for patients in need of breakthroughs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ascidian Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Murray
Likely contact at this company
••••••••@••••••••

See Murray's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ascidian Therapeutics's next move

Learn about Strategic plan

Ascidian Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.